Pharmacologic Management of Urinary Urgency in Amyloidosis Introduction Urinary frequency and urgency are troublesome and frequent symptoms in systemic amyloidosis […]

First-Line Pharmacological Treatment for Orthostatic Hypotension in Amyloidosis: Midodrine and Droxidopa Introduction Orthostatic hypotension (OH) is common and disabling in

Supine Hypertension in Amyloidosis: Definition and Management Strategies Introduction Supine hypertension has long been an underdiagnosed and undertreated complication in

Implantable Cardioverter-Defibrillators (ICDs) in Cardiac Amyloidosis: Do They Really Help? 1. Introduction Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy due

Digoxin Use in Cardiac Amyloidosis: Risks, Cautions, and Current Evidence 1. Introduction Digoxin traditionally has been contraindicated in cardiac amyloidosis

Non-Pharmacological Treatments for Orthostatic Hypotension in Amyloidosis Introduction Orthostatic hypotension (OH) is a frequent complication in systemic amyloidosis, especially if

Evaluation of Cerebral Amyloid Angiopathy (CAA): Role of MRI and Amyloid PET Introduction Cerebral amyloid angiopathy (CAA) is a neurologic

Orthostatic Hypotension in Amyloidosis: Definition and Clinical Significance Introduction Orthostatic hypotension (OH) is a prevalent and frequently disabling complication of

CNS Complications in ATTRv Amyloidosis: Leptomeningeal Amyloidosis and Neurological Manifestations Introduction Amyloidosis is a disparate group of disease conditions due

Amitriptyline and Neuropathic Pain in Amyloidosis: Risks and Considerations 1. Introduction Neuropathic pain is one of the frequent complications of